European MedTech Events in June 2026: A Look at Key Participants and Industry Focus
4 min readBy Dr. Rina Sato · Editor-in-Chief
June 2026 marks a crucial period for the European medical technology sector, with several key events scheduled across the continent. These gatherings serve as vital platforms for industry professionals to discuss advancements, navigate regulatory landscapes, and foster collaborations. While a singular "EuroMedtec 2026" event was not specifically identified, the collective impact of these diverse summits and expos promises a comprehensive look at the industry's trajectory. From regulatory compliance to manufacturing innovation and strategic development, these events attract a wide array of medical device companies. Understanding the focus of these gatherings and the companies involved provides insight into the current priorities shaping the global medical technology landscape. Industry professionals networking at a European medical technology event.
Overview of Key European MedTech Events and Participants
Several prominent events are slated for June 2026 across Europe, each contributing to the discourse on medical device innovation and regulation. The European Medical Device Summit in Düsseldorf, the MedTech Summit in Berlin, and the Med-Tech Innovation Expo in Birmingham are among the key gatherings. These events draw a diverse group of manufacturers and service providers. Below is an overview of some companies noted as participants or having executive involvement in related summits.
Company
Headquarters (HQ)
Founded Year
Key Product Categories
Edwards Lifesciences
Irvine, California, USA
1958
Structural heart disease technologies, critical care monitoring
Johnson & Johnson (MedTech)
New Brunswick, New Jersey, USA
1886
Surgical technologies, orthopaedics, vision care, interventional solutions
Olympus Corporation
Tokyo, Japan
1919
Medical endoscopes, therapeutic devices, surgical energy instruments
Acute and chronic therapies, sterile IV solutions, renal care, hospital products
Profiles of Participating Companies
Edwards Lifesciences
Edwards Lifesciences, with its HQ in Irvine, California, USA, was founded in 1958. The company manufactures medical technologies within the structural heart disease and critical care monitoring segments. Its product lines include devices for various procedural and diagnostic applications.
Johnson & Johnson (MedTech)
Johnson & Johnson's MedTech segment, headquartered in New Brunswick, New Jersey, USA, traces its origins to the company's founding in 1886. This segment offers a broad portfolio of medical technologies, including surgical products, orthopaedic solutions, vision care, and interventional solutions, serving healthcare providers globally.
Olympus Corporation
Olympus Corporation, established in 1919 and based in Tokyo, Japan, is a global manufacturer of optical and digital precision technology. Its medical business unit focuses on product lines such as medical endoscopes, therapeutic devices, and surgical energy instruments, serving various medical procedural areas.
Boston Scientific
Boston Scientific, founded in 1979 and headquartered in Marlborough, Massachusetts, USA, develops and manufactures a variety of medical devices. Its business units encompass solutions for interventional cardiology, peripheral interventions, urology, neuromodulation, and endoscopy, serving diverse medical segments.
Getinge
Getinge, with its HQ in Getinge, Sweden, was founded in 1904. The company provides products and solutions for surgery, intensive care, infection control, and sterile reprocessing. Its offerings are utilized in healthcare and life science facilities worldwide.
Elekta
Elekta, founded in 1972 and based in Stockholm, Sweden, is a company focused on precision radiation medicine. Its product lines include advanced oncology treatment solutions and related software platforms within the radiation medicine segment.
Philips (Health Technology)
Philips Health Technology, part of the larger Philips conglomerate founded in 1891 and based in Amsterdam, Netherlands, offers a wide array of health technology solutions. These include product categories such as diagnostic imaging systems, image-guided therapy platforms, patient monitoring devices, and health informatics.
Roche (Diagnostics)
Roche Diagnostics, a division of the Swiss company founded in 1896 with HQ in Basel, Switzerland, is a leading provider of in-vitro diagnostics. Its product lines encompass a vast range of diagnostic tests and systems for personalized healthcare and laboratory applications.
Baxter International
Baxter International, founded in 1931 and headquartered in Deerfield, Illinois, USA, develops and manufactures a diverse portfolio of medical products. Its offerings include acute and chronic therapies, sterile IV solutions, renal care products, and various hospital products for use across multiple settings.
Industry Context: Navigating European MedTech in 2026
The June 2026 events underscore the dynamic environment within the European medical technology industry. A central theme across these gatherings is the ongoing adaptation to the European Medical Device Regulation (EUMDR) and In Vitro Diagnostic Regulation (IVDR). Companies are actively seeking strategies to ensure compliance while continuing to innovate. Beyond regulation, the industry's focus extends to the integration of advanced technologies. Discussions around Software as a Medical Device (SaMD) and Artificial Intelligence (AI) in healthcare are prominent, reflecting a push towards digital transformation in device development and patient care. Furthermore, topics such as biocompatibility and global market access highlight the complex considerations for manufacturers operating in an interconnected world. Abstract visualization of medical technology, AI, and regulatory compliance. As the medical technology landscape continues to evolve, these European events in June 2026 offer crucial insights into the industry's direction. Which specific product category or regulatory challenge do you find most impactful for the future of medical devices?
